May 23, 2017 | Story Review

Could an expensive chemotherapy drug treat severe asthma? It’s too soon to know

Considering how preliminary this trial is, there’s not a lot of news value to lay readers who are hoping for new asthma treatment options.

4 Star

Could Cancer Drug Gleevec Help With Severe Asthma?

May 22, 2017 | Story Review

Keytruda for bladder cancer: No independent scrutiny of Merck-reported results

Details that patients care about–such as the incredibly steep price tag and potential for adverse effects–didn’t get much attention in this story.

3 Star

Merck says test shows Keytruda improves survival for bladder cancer patients

May 22, 2017 | Story Review

Bloomberg story provides clear-eyed view of trendy neurofeedback brain-training clinics

Expert sources and a review of the scientific literature ground the story and help balance the anecdotes.

5 Star

Neurofeedback Could Fight Depression–or Just Empty Your Wallet

May 18, 2017 | Story Review

How solid is the evidence for an implantable sleep apnea device? NBC’s story doesn’t say

There is much more evidence showing CPAP is proven to improve the very same outcomes for which the new device is touted. This point should have been included

3 Star

New Technology May Help Ease Sleep Apnea

May 17, 2017 | Story Review

‘Baby aspirin may reduce risk of breast cancer,’ says Washington Post, omitting some major limitations of the study

The story also doesn’t include any sourcing, nor how this work fits into the existing body of research on aspirin and cancer.

3 Star

For women, baby aspirin may reduce risk of breast cancer

May 16, 2017 | Story Review

Blood thinners may prevent dementia in atrial fibrillation patients–or they may not

The story reminds readers that the study conclusions are “preliminary,” an important cautionary note, but then leads with rather strong causal statement.

3 Star

Blood Thinners May Prevent Dementia in Atrial Fibrillation Patients

May 15, 2017 | Story Review

USA Today story based on one anecdote serves as promotional megaphone for Microsoft

Seeing is not believing when it comes to a medical intervention; many factors, including a placebo effect, can make an intervention seem like it works when it doesn’t.

2 Star

Microsoft shows off watch that quiets Parkinson's tremors

May 12, 2017 | Story Review

Except for needing more sources, Reuters Health story on Graves’ disease is well-reported

The story does a lot of things well–it adequately quantifies the benefits from use of the drug, as well as outlining the potential risks associated with it.

4 Star

Experimental drug reduces thyroid-associated ‘Graves' eyes,’

Toolkit

Tips for Understanding Studies

View More

Toolkit